glp-1 therapy protein intake optimization Nutritional priorities to support for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society - Optimizing GLP-1 therapies for obesity

#Health #Pharma #WeightLoss #DiabetesCare #EyeHealth #PatientSafety #Mounjaro #Wegovy #Phramavoice.in #Pharmanews

Sitagliptin is the first of a class of drugs to be approved that mimics the actions of the dipeptidyl peptidase-4 (DPP-4) enzyme.

Henney 2024) demonstrated a potentially meaningful reduction in incident pneumonia with GLP-1 RAs compared with dipeptidyl peptidase-4 (DPP-4) inhibitors (hazard ratio [HR] 0.60, 95% confidence interval [CI] 0.580.62

It seems like asking someone to stay on a weekly injection indefinitely is a much harder sell

Please visit our product directions page for information on how to use these supplements to support your optimal digestion while taking GLP-1 medications